Project Details
| Status | Active |
|---|---|
| Effective start/end date | 7/19/24 → 7/19/27 |
Funding
- Ergomed Clinical Research Inc. (Prot #ALE.C04.01 // Prot #ALE.C04.01)
- Alentis Therapeutics AG (Prot #ALE.C04.01 // Prot #ALE.C04.01)
Prot #ALE.C04.01: A Phase I/II, Open-Label, Multi-Center Study of ALE.C04 (anti-Claudin-1Antibody) as a Single Agent and in Combination with Pembrolizumab (anti-PD-1 antibody) in Adult Patients with Recurrent or Metastatic (R/M) Head and Neck Squamous Cel
- Lorch, Jochen Hanns-Martin (PD/PI)
Project: Research project